Skip to content

OviTex® LPR F10244-0909LRecalls & reported problems

Aroa Biosurgery Limited · The OviTex® Reinforced Tissue Matrix Device is a sterile reinforced matrix device comprised of non-dermal sourced layers of extracellular matrix (ECM) (ovine (sheep) derived ECM), paired with a minimal suture footprint. OviTex Reinforced Tissue Matrix Device provides an alternative device solution to permanent synthetic, resorbable/bioabsorbable synthetic, and biologic meshes. The device remodels and helps regenerate tissue while reinforcing the repair and providing structural support. Reinforced tissue matrices enhance performance while maintaining compatibility with the body. The OviTex Reinforced Tissue Matrix Device is used for hernia repair and abdominal wall reconstruction. · Class 2 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
5
Deaths reported
0
Injuries reported
5
Recalls naming it
0

Summary

The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 09421904065765), received between Jan 17, 2022 and Aug 19, 2026 — classified as 5 injuries.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 1 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 1 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem5

Patient problems

  • Adhesion(s)4
  • Abscess1
  • Bowel Perforation1
  • Erosion1
  • Erythema1
  • Fluid Discharge1
  • Obstruction/Occlusion1

Recent adverse event reports

The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.

  • InjuryAug 19, 2026Adverse Event Without Identified Device or Use Problem

    A patient underwent open ventral hernia repair for a 4-6cm defect with 9x9cm OviTex LPR placed preperitoneally. The patient returned approximately one week later with redness, swelling, and fluid build up. The surgeon reoperated to explant the device.

    Patient problems: Erythema; Fluid Discharge

    MAUDE report 50329015 ↗
  • InjuryApr 1, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A PATIENT UNDERWENT HERNIA REPAIR WITH OVITEX LPR ON (B)(6) 2025. THE SURGEON SEWED THE DEVICE IN PLACE AND ALSO UTILIZED A CAPSURE TACKER (PERMANENT STAINLESS STEEL AND PEEK). THE PATIENT RETURNED SYMPTOMATIC FOR ABSCESS AND UNDERWENT EXPLORATORY LAPAROTOMY APPROXIMATELY 5 WEEKS LATER. UPON REOPERATION, IT WAS NOTED THAT ADHESIONS WERE PRESENT ALONG WITH SOME EROSION INTO THE BOWEL. THE PRODUCT AND A PORTION OF THE BOWEL WERE EXCISED.

    Patient problems: Abscess; Adhesion(s); Bowel Perforation; Erosion

    MAUDE report 21746824 ↗
  • InjuryOct 5, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A PATIENT RETURNED TO THE HOSPITAL WITH ABDOMINAL PAIN ON (B)(6) 23 AFTER UMBILICAL HERNIA REPAIR WITH OVITEX LPR ORIGINALLY PERFORMED ON (B)(6) 2023. A CT SCAN SHOWED BOWEL OBSTRUCTION WHICH WAS ADDRESSED WITH SURGERY AND PARTIAL DEVICE REMOVAL. IT WAS NOTED THAT THE BOWEL WAS STUCK IN TWO PLACES REQUIRING SHARP DISSECTION AND PARTIAL BOWEL RESECTION. A BOWEL ANASTOMOSIS WAS PERFORMED AND SURGERY COMPLETED WITHOUT FURTHER REINFORCEMENT.

    Patient problems: Adhesion(s); Obstruction/Occlusion

    MAUDE report 17878158 ↗
  • InjuryJan 17, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    AN OVITEX LPR DEVICE WAS USED TO REINFORCE AND REPAIR THE ABDOMINAL WALL AFTER PROSTATECTOMY IN THE INGUNAL SPACE. IT WAS REPORTED THAT THE PATIENT EXPERIENCED SYMPTOMS OF A SMALL BOWEL OBSTRUCTIONS AND UNDERWENT A SECONDARY SURGERY WHERE ADHESIONS TO THE DEVICE WERE FOUND AND WERE TAKEN DOWN.

    Patient problems: Adhesion(s)

    MAUDE report 13266898 ↗
  • InjuryJan 17, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    AN OVITEX LPR DEVICE WAS USED TO REINFORCE AND REPAIR THE ABDOMINAL WALL AFTER PROSTATECTOMY IN THE INGUNAL SPACE. IT WAS REPORTED THAT THE PATIENT EXPERIENCED SYMPTOMS OF A SMALL BOWEL OBSTRUCTIONS AND UNDERWENT A SECONDARY SURGERY WHERE ADHESIONS TO THE DEVICE WERE FOUND AND WERE TAKEN DOWN.

    Patient problems: Adhesion(s)

    MAUDE report 13266628 ↗

Other Mesh, Surgical devices

All Mesh, Surgical devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page